Scholarlink

Background <p>Cervical cancer continues to pose a significant global health issue, often exacerbated by challenges such as chemoresistance and toxicity. Phytochemicals such as thymoquinone and curcumin exhibit promising multi-targeted anticancer properties.</p> Purpose <p>This study investigated the synergistic cytotoxic and pro-apoptotic effects of Thymoquinone (TQ) and Curcumin (CUR) on HeLa cells and elucidated the underlying mechanisms.</p> Methods <p>HeLa cells were treated with TQ (0–100 µM), CUR at 30%, 50%, and 70% inhibitory concentrations (IC₃₀, IC₅₀, IC₇₀), and fixed-ratio combinations for 24, 48, 72, and 96. Cytotoxicity was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, and synergy was assessed using the Chou–Talalay method. Morphological alterations and apoptotic features were examined by phase-contrast microscopy and acridine orange/ethidium bromide (AO/EtBr) dual staining. Apoptotic signalling was evaluated through reactive oxygen species (ROS) generation, mitochondrial membrane potential (ΔΨm), and expression of caspase-9 and caspase-3.</p> Results <p>TQ and CUR reduced HeLa cell viability dose-dependently. Combination treatment showed time-dependent interaction, with additive effects at 24&#xa0;h, antagonist-to-additive effects at 48&#xa0;h, and synergistic cytotoxicity at longer exposures. Synergy emerged at 72&#xa0;h and peaked at 96&#xa0;h, particularly at lower inhibitory concentrations (CI₃₀ = 0.12). The combination induced apoptotic features, including nuclear condensation, membrane blebbing, mitochondrial depolarization, elevated ROS levels, and caspase-9 and caspase-3 activation, indicating intrinsic, caspase-dependent apoptosis.</p> Conclusion <p>TQ and CUR synergistically induce apoptosis in HeLa cells through ROS-mediated mitochondrial dysfunction and caspase activation, highlighting their potential as a phytochemical-based adjunct strategy for cervical cancer management. Hence, further in vivo studies are warranted.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Synergistic anticancer effects of thymoquinone and curcumin via ROS-mediated mitochondrial apoptosis in HeLa cells

  • 期刊论文

  • 发表日期：

    2026年3月31日

查看全文
  • Ummai Habiba,
  • Najmul Islam

摘要

Background

Cervical cancer continues to pose a significant global health issue, often exacerbated by challenges such as chemoresistance and toxicity. Phytochemicals such as thymoquinone and curcumin exhibit promising multi-targeted anticancer properties.

Purpose

This study investigated the synergistic cytotoxic and pro-apoptotic effects of Thymoquinone (TQ) and Curcumin (CUR) on HeLa cells and elucidated the underlying mechanisms.

Methods

HeLa cells were treated with TQ (0–100 µM), CUR at 30%, 50%, and 70% inhibitory concentrations (IC₃₀, IC₅₀, IC₇₀), and fixed-ratio combinations for 24, 48, 72, and 96. Cytotoxicity was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, and synergy was assessed using the Chou–Talalay method. Morphological alterations and apoptotic features were examined by phase-contrast microscopy and acridine orange/ethidium bromide (AO/EtBr) dual staining. Apoptotic signalling was evaluated through reactive oxygen species (ROS) generation, mitochondrial membrane potential (ΔΨm), and expression of caspase-9 and caspase-3.

Results

TQ and CUR reduced HeLa cell viability dose-dependently. Combination treatment showed time-dependent interaction, with additive effects at 24 h, antagonist-to-additive effects at 48 h, and synergistic cytotoxicity at longer exposures. Synergy emerged at 72 h and peaked at 96 h, particularly at lower inhibitory concentrations (CI₃₀ = 0.12). The combination induced apoptotic features, including nuclear condensation, membrane blebbing, mitochondrial depolarization, elevated ROS levels, and caspase-9 and caspase-3 activation, indicating intrinsic, caspase-dependent apoptosis.

Conclusion

TQ and CUR synergistically induce apoptosis in HeLa cells through ROS-mediated mitochondrial dysfunction and caspase activation, highlighting their potential as a phytochemical-based adjunct strategy for cervical cancer management. Hence, further in vivo studies are warranted.